KTTA
Pasithea Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.58
−0.07%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-42.7%
Return on equity
-41.2%
Return on assets
-48.1%
Return on invested capital
0.00x
Asset turnover
-$17.8M
Cash from operations
$1.4K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026